Innate Pharma SA
NASDAQ:IPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
NASDAQ:IPHA
|
FR |
Multiples-Based Value
The Multiples-Based Value for
Innate Pharma SA (IPHA) under the Base Case is 2.097 USD.
Compared with the current market price of 1.772 USD, the stock appears
Undervalued by 16% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.